Detalhe da pesquisa
1.
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.
Ann Surg Oncol
; 29(13): 8597-8605, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36070113
2.
ASO Visual Abstract: Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.
Ann Surg Oncol
; 29(13): 8608-8609, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36207480
3.
Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer.
Oncotarget
; 7(39): 64089-64099, 2016 Sep 27.
Artigo
Inglês
| MEDLINE | ID: mdl-27577069